Frequency of viremic episodes in HIV-infected women initiating antiretroviral therapy during pregnancy: A cohort study

Clinical Infectious Diseases

Volumn 64, Issue 4, 2017, Pages 422-427

  Myer, Landon ^a,b   Dunning, Lorna ^a   Lesosky, Maia ^a   Hsiao, Nei Yuan ^c   Phillips, Tamsin ^a,b   Petro, Greg ^a   Zerbe, Allison ^d   McIntyre, James A ^a,e   Abrams, Elaine J ^d,f  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b School of Public Health and Family Medicine   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d Columbia University Mailman School of Public Health ^*  (United States)

^e ANOVA HEALTH INSTITUTE   (South Africa)

^f Columbia University ^*  (United States)

Author keywords

Antiretroviral therapy; HIV; Postpartum; Pregnancy; Viral load

Indexed keywords

EFAVIRENZ; EMTRICITABINE; NEVIRAPINE; TENOFOVIR; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PUERPERIUM; THIRD TRIMESTER PREGNANCY; VIREMIA; VIRUS LOAD; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOUTH AFRICA; SUSTAINED VIROLOGIC RESPONSE; VIROLOGY; YOUNG ADULT;

ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOUTH AFRICA; SUSTAINED VIROLOGIC RESPONSE; VIRAL LOAD; VIREMIA; YOUNG ADULT;

EID: 85015814841     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw792     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep 2013; 62:148-51.
2. Myer L, Phillips T, Manuelli V, McIntyre J, Bekker LG, Abrams EJ. Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa. J Acquir Immune Defic Syndr 2015; 69:57-65.
3. World Health Organization. WHO consolidated guidelines on the use of antiretrovirals for treating and preventing HIV infection. 2nd ed. Geneva, Switzerland: WHO, 2016.
4. Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: A systematic review and meta-analysis. AIDS 2012; 26:2039-52.
5. Phillips T, Thebus E, Bekker LG, Mcintyre J, Abrams EJ, Myer L. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: A cohort study. J Int AIDS Soc 2014; 17:19242.
6. Haas AD, Tenthani L, Msukwa MT, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study. Lancet HIV 2016; 3:e175-82.
7. Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa. Sustainable HIV treatment in Africa through viral-loadinformed differentiated care. Nature 2015; 528:S68-76.
8. Myer L, Phillips TK, Zerbe A, et al. Optimizing antiretroviral therapy (ART) for maternal and child health (MCH): rationale and design of the MCH-ART study. J Acquir Immune Defic Syndr 2016; 72:S189-96.
9. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva, Switzerland: WHO; 2013.
10. South African National Department of Health (NDOH). National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Pretoria, South Africa: NDOH, 2015.
11. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Available at: http://aidsinfo.nih. gov/contentfiles/lvguidelines/PerinatalGL.pdf. Accessed 1 December 2016.
12. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999; 341:394-402.
13. Davis NL, Miller WC, Hudgens MG, et al. Maternal and breast milk viral load: impacts of adherence on peri-partum HIV infections averted-the BAN study [manuscript published online ahead of print 1 August 2016]. J Acquir Immune Defic Syndr 2016. doi:10.1097/QAI.0000000000001145.
14. Hodgson I, Plummer ML, Konopka SN, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS One 2014; 9:e111421.
15. Huntington S, Thorne C, Newell ML, et al; UK Collaborative HIV Cohort (UK CHIC) Study and the UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC). The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy. AIDS 2015; 29:2269-78.
16. Adams JW, Brady KA, Michael YL, Yehia BR, Momplaisir FM. Postpartum engagement in HIV care: an important predictor of long-term retention in care and viral suppression. Clin Infect Dis 2015; 61:1880-7.
17. Myer L, Phillips TK, McIntyre JA, et al. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa [manuscript published online ahead of print 28 June 2016]. HIV Med 2016. doi:10.1111/hiv.12397.
18. Mwapasa V, Rogerson SJ, Kwiek JJ, et al. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS 2006; 20:1869-77.
19. Jamieson DJ, Sibailly TS, Sadek R, et al. HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire. J Acquir Immune Defic Syndr 2003; 34:430-6.
20. Chasela C, Chen YQ, Fiscus S, et al. Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa. Pediatr Infect Dis J 2008; 27:251-6.
21. World Health Organization. Guideline: updates on HIV and infant feeding. Geneva, Switzerland: WHO, 2016.
22. Centers for Disease Control and Prevention. Scale-up of HIV viral load monitoring- seven sub-Saharan African countries. MMWR Morb Mortal Wkly Rep 2013; 64:1287-90.
23. Ouattara EN, Robine M, Eholie SP, et al. Laboratory monitoring of antiretroviral therapy for HIV infection: cost-effectiveness and budget impact of current and novel strategies. Clin Infect Dis 2016; 62:1454-62.
24. Roberts T, Cohn J, Bonner K, Hargreaves S. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis 2016; 62:1043-8.